We encountered a patient with cystoid macular edema (CME) secondary to paclitaxel use. A 57-year-old man presented with gradual decreased bilateral vision. His chemotherapeutic regimen consisted of bevacizumab, paclitaxel (175 mg/m(2) for 5 months), and carboplatin. Optical coherence tomography imaging revealed bilateral CME greater than 500 μm. However, one year later, visual acuity was improved, best-corrected Snellen visual acuity was 40 / 80 in each eye, and CME was spontaneously improved. Our study confirmed that macular edema associated with paclitaxel use shows spontaneous resolution and improvement of visual acuity after a change of chemotherapeutic regimen.
CITATION STYLE
Ham, D. S., Lee, J. E., Kim, H. W., & Yun, I. H. (2012). A case of cystoid macular edema associated with Paclitaxel chemotherapy. Korean Journal of Ophthalmology : KJO, 26(5), 388–390. https://doi.org/10.3341/kjo.2012.26.5.388
Mendeley helps you to discover research relevant for your work.